Gilead Sciences Inc.

01/12/2021 | Press release | Distributed by Public on 01/12/2021 07:06

Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus